Arock M - Search Results

1

Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.

Zappulla JP, Dubreuil P, Desbois S, Létard S, Hamouda NB, Daëron M, Delsol G, Arock M, Liblau RS. Zappulla JP, et al. Among authors: arock m. J Exp Med. 2005 Dec 19;202(12):1635-41. doi: 10.1084/jem.20050807. Epub 2005 Dec 13. J Exp Med. 2005. PMID: 16352739 Free PMC article.

2

Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.

Daëron M, Malbec O, Latour S, Arock M, Fridman WH. Daëron M, et al. Among authors: arock m. J Clin Invest. 1995 Feb;95(2):577-85. doi: 10.1172/JCI117701. J Clin Invest. 1995. PMID: 7860741 Free PMC article.

3

c-Kit and c-kit mutations in mastocytosis and other hematological diseases.

Boissan M, Feger F, Guillosson JJ, Arock M. Boissan M, et al. Among authors: arock m. J Leukoc Biol. 2000 Feb;67(2):135-48. doi: 10.1002/jlb.67.2.135. J Leukoc Biol. 2000. PMID: 10670573 Review.

4

Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma.

Plo I, Lautier D, Casteran N, Dubreuil P, Arock M, Laurent G. Plo I, et al. Among authors: arock m. Oncogene. 2001 Oct 11;20(46):6752-63. doi: 10.1038/sj.onc.1204877. Oncogene. 2001. PMID: 11709710

5

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.

Féger F, Ribadeau Dumas A, Leriche L, Valent P, Arock M. Féger F, et al. Among authors: arock m. Int Arch Allergy Immunol. 2002 Feb;127(2):110-4. doi: 10.1159/000048179. Int Arch Allergy Immunol. 2002. PMID: 11919418 Review.

6

Mast cells: new targets for multiple sclerosis therapy?

Zappulla JP, Arock M, Mars LT, Liblau RS. Zappulla JP, et al. Among authors: arock m. J Neuroimmunol. 2002 Oct;131(1-2):5-20. doi: 10.1016/s0165-5728(02)00250-3. J Neuroimmunol. 2002. PMID: 12458032 Review.

7

Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms.

Zermati Y, De Sepulveda P, Féger F, Létard S, Kersual J, Castéran N, Gorochov G, Dy M, Ribadeau Dumas A, Dorgham K, Parizot C, Bieche Y, Vidaud M, Lortholary O, Arock M, Hermine O, Dubreuil P. Zermati Y, et al. Among authors: arock m. Oncogene. 2003 Feb 6;22(5):660-4. doi: 10.1038/sj.onc.1206120. Oncogene. 2003. PMID: 12569358

8

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Varadaradjalou S, Féger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock M. Varadaradjalou S, et al. Among authors: arock m. Eur J Immunol. 2003 Apr;33(4):899-906. doi: 10.1002/eji.200323830. Eur J Immunol. 2003. PMID: 12672055 Free article.

9

Establishment and characterization of a new human erythroleukemic cell line, ERY-1.

Ribadeau Dumas A, Hamouda NB, Leriche L, Piffaut MC, Bonnemye P, Kuen RL, Tricottet V, Merle-Beral H, N'Guyen Khac F, Arock M. Ribadeau Dumas A, et al. Among authors: arock m. Leuk Res. 2004 Dec;28(12):1329-39. doi: 10.1016/j.leukres.2004.04.013. Leuk Res. 2004. PMID: 15475075

10

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells.

Gabillot-Carré M, Lepelletier Y, Humbert M, de Sepuvelda P, Hamouda NB, Zappulla JP, Liblau R, Ribadeau-Dumas A, Machavoine F, Letard S, Baude C, Hermant A, Yang Y, Vargaftig J, Bodemer C, Morelon E, Lortholary O, Recher C, Laurent G, Dy M, Arock M, Dubreuil P, Hermine O. Gabillot-Carré M, et al. Among authors: arock m. Blood. 2006 Aug 1;108(3):1065-72. doi: 10.1182/blood-2005-06-2433. Epub 2006 Apr 4. Blood. 2006. PMID: 16597595 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters